Back
Waters Corp. Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison
Buy
54
WAT
Waters Corp.
Last Price:
$381.97
Seasonality Move:
6.57%
Sell
41
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$399.87
Seasonality Move:
1.76%
Buy
54
Waters Corp. (WAT)
is a Buy
Is Waters Corp. a Buy, Sell or Hold?
-
The current Waters Corp. [WAT] share price is $381.96. The Score for WAT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
WAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Sell
Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $397.65. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
WAT Stock Price Chart
What is Waters Corp.'s stock price today?
-
The Waters Corp. share price today is $381.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals, Inc.'s stock price today?
-
The Alnylam Pharmaceuticals, Inc. share price today is $397.65Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
WAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 103.29 | Buy |
| Relative Strength Index (14 RSI): | 48.83 | Sell |
| Chaikin Money Flow: | 402263 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (380.12 - 396.88) | Sell |
| Bollinger Bands (100): | (303.64 - 383.04) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -12.2 | Sell |
| Relative Strength Index (14 RSI): | 37.79 | Sell |
| Chaikin Money Flow: | -650289 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (391.88 - 446.1) | Sell |
| Bollinger Bands (100): | (422.72 - 470.24) | Sell |
WAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 383.64 | Sell |
| 20-day SMA: | 385.4 | Sell |
| 50-day SMA: | 379.24 | Buy |
| 200-day SMA: | 339.35 | Buy |
| 8-day EMA: | 358.45 | Buy |
| 20-day EMA: | 255.17 | Buy |
| 50-day EMA: | 136.02 | Buy |
| 200-day EMA: | 39.78 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 400.21 | Sell |
| 20-day SMA: | 411.45 | Sell |
| 50-day SMA: | 436.15 | Sell |
| 200-day SMA: | 371.13 | Buy |
| 8-day EMA: | 399.81 | Sell |
| 20-day EMA: | 410 | Sell |
| 50-day EMA: | 426.22 | Sell |
| 200-day EMA: | 383.9 | Buy |
Waters Corp. Earnings Growth & WAT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $1.40 per share.
Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.23 per share, and an increase next year of $6.60 per share.
Waters Corp. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||